hypersalivation
Showing 1 - 25 of 44
Prevalence of Sialorrhea in Patients Treated With Clozapine
Active, not recruiting
- Sialorrhea
- +2 more
- Evaluation of sialorrhea through questionnaires that measure daytime and nighttime sialorrhea and the impact on quality of life.
-
Barcelona, SpainCentre Forum Parc de Salut Mar
Mar 15, 2021
Postoperative Vomiting, Postoperative Nausea, Postoperative Delirium Trial in Istanbul (Group N; neostigmine+atropine, GROUP S;
Active, not recruiting
- Postoperative Vomiting
- +2 more
- Group N; neostigmine+atropine
- GROUP S; decurarized with sugammadex.
-
Istanbul, Maltepe, TurkeyMarmara University
Nov 8, 2022
Generalized Convulsive Status Epilepticus Trial in Sohag (Ketamine, Midazolam, Placebo)
Recruiting
- Generalized Convulsive Status Epilepticus
- Ketamine
- +2 more
-
Sohag, EgyptSohag University Hospital
Mar 21, 2023
Complication of Anesthesia Trial in Karachi (comparison of group-I (low dose propofol with isoflurane))
Completed
- Complication of Anesthesia
- comparison of group-I (low dose propofol with isoflurane)
-
Karachi, Sindh, PakistanOperating room at Aga Khan University Hospital
Feb 11, 2021
Schizophrenia Trial in Baltimore (Anti-inflammatory Combination Therapy, Placebo)
Completed
- Schizophrenia
- Anti-inflammatory Combination Therapy
- Placebo
-
Baltimore, MarylandMaryland Psychiatric Research Center
Mar 1, 2022
Snakebite Trial in Patuakhali (Snakebite prevention and first aid)
Enrolling by invitation
- Snakebite
- Snakebite prevention and first aid
-
Patuakhali, BangladeshKalapara Upazila and Upazila Health Complex
May 14, 2023
Anxiety Postoperative Trial in Adana (Dental Treatment)
Completed
- Anxiety Postoperative
- Dental Treatment
-
Adana, TurkeyCukurova University
Nov 10, 2020
Head Neck Cancer, Carcinoma, Squamous Cell, Tumors, Oral Trial in Chicago, Dallas (Intensity Modulated Radiation Therapy, chemo)
Completed
- Head and Neck Cancer
- +3 more
- Intensity Modulated Radiation Therapy
- chemotherapy
-
Chicago, Illinois
- +1 more
Feb 16, 2022
COVID-19, SARS-CoV-2 Trial in Ciudad de México (Pyridostigmine Bromide, Placebo)
Unknown status
- COVID-19
- SARS-CoV-2
- Pyridostigmine Bromide
- Placebo
-
Ciudad de México, Tlalpan, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Jul 6, 2020
Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,
Active, not recruiting
- Recurrent Lymphoma
- +5 more
- Irinotecan
- +2 more
-
Birmingham, Alabama
- +19 more
Oct 20, 2022
Tetrahydrobiopterin Deficiencies, Hyperphenylalaninemia, Non-Phenylketonuric Trial in Germany, United States (Phenoptin)
Completed
- Tetrahydrobiopterin Deficiencies
- Hyperphenylalaninemia, Non-Phenylketonuric
-
Los Angeles, California
- +9 more
Sep 24, 2020
Carcinoma, Squamous Cell of Head and Neck Trial in United States (Cetuximab, PD 0332991)
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Cetuximab
- PD 0332991
-
Atlanta, Georgia
- +4 more
Nov 1, 2022
Post-operative Residual Curarization Trial (Sugammadex Injection [Bridion], Neostigmine)
Unknown status
- Post-operative Residual Curarization
- Sugammadex Injection [Bridion]
- Neostigmine
- (no location specified)
Jun 21, 2019
Ketamine Versus Midazolam for Prehospital Agitation
Completed
- Agitation
- Ketamine-based protocol
- Midazolam-based protocol
-
Minneapolis, MinnesotaHennepin County Medical Center
Apr 3, 2019
Malignant Glioma Trial in Durham (Sym004 - 18 mg/kg, Sym004 - 24 mg/kg)
Completed
- Malignant Glioma
- Sym004 - 18 mg/kg
- Sym004 - 24 mg/kg
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center
Jul 23, 2020
Glioblastoma Multiforme Trial in United States (Bevacizumab, BKM120)
Completed
- Glioblastoma Multiforme
-
New Haven, Connecticut
- +7 more
Jun 8, 2020
Cannabis-Related Disorder, Substance-Related Disorders, Schizophrenia Trial in United States (clozapine, risperidone)
Completed
- Cannabis-Related Disorder
- +3 more
-
Concord, New Hampshire
- +4 more
Jul 9, 2019
Schizophrenia, Dual Diagnosis, Schizoaffective Disorder Trial in United States (Clozapine, Treatment as usual)
Completed
- Schizophrenia
- +4 more
- Clozapine
- Treatment as usual
-
Los Angeles, California
- +3 more
Feb 28, 2019
Schizophrenia, Psychotic Disorders, Substance Abuse Trial in United States (Risperidone Long Acting, oral risperidone)
Completed
- Schizophrenia
- +3 more
- Risperidone Long Acting
- oral risperidone
-
Miami, Florida
- +7 more
Apr 16, 2019
Smoking Cessation Trial in Boston (D-cycloserine, Placebo)
Completed
- Smoking Cessation
- D-cycloserine
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital - Center For Addiction Medicine
Aug 29, 2018
Autistic Disorder Trial in Indianapolis (Aripiprazole, Placebo, D-cycloserine)
Completed
- Autistic Disorder
- Aripiprazole
- +2 more
-
Indianapolis, IndianaRiley Hospital for Children, Christian Sarkine Autism Treatment
Mar 29, 2019
Pervasive Developmental Disorder Trial in Indianapolis (Aripiprazole oral product, Placebo oral capsule)
Completed
- Pervasive Developmental Disorder
- Aripiprazole oral product
- Placebo oral capsule
-
Indianapolis, IndianaRiley Hospital for Children, Christian Sarkine Autism Treatment
Dec 7, 2018
Sialorrhea (Excessive Drooling) Trial in Paris, Toulouse, Bordeaux (NH004 tropicamide, NH004 Placebo)
Completed
- Sialorrhea (Excessive Drooling)
- NH004 tropicamide
- NH004 Placebo
-
Paris, Cedrex 13, France
- +2 more
Dec 8, 2015